35633-91-1

Usage

Uses

Used in Pharmaceutical Industry:
3,4-DIBROMO-2-NITROTHIOPHENE is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its reactivity and electron-withdrawing properties enable the development of new drugs with improved therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical industry, 3,4-DIBROMO-2-NITROTHIOPHENE serves as a crucial component in the production of pesticides and other agrochemicals. Its unique structure and reactivity contribute to the creation of effective and targeted pest control solutions.
Used in Chemical Research:
3,4-DIBROMO-2-NITROTHIOPHENE is utilized as a research compound in various scientific studies. Its properties make it an interesting subject for exploring new chemical reactions, synthesis methods, and potential applications in different fields.
Used in Industrial Applications:
Due to its versatility and reactivity, 3,4-DIBROMO-2-NITROTHIOPHENE is employed in various industrial applications, including the synthesis of dyes, plastics, and other specialty chemicals. Its electron-withdrawing properties and unique structure make it a valuable component in the development of innovative materials and products.

Upstream product

• 3141-26-2 3,4-dibromothiophene 

Downstream Products

• 85598-49-8 bromo-4 nitro-2 thiophene 
• 82834-62-6 (4-Bromo-2-nitro-thiophen-3-yl)-phenyl-amine 
• 93102-40-0 4-bromo-3-(2'-formylphenoxy)-2-nitrothiophene 

Relevant academic research and scientific papers

Towards novel thieno-fused subporphyrazines via functionalized thiophene precursors

Thieno-fused subporphyrazines (TPs) containing a central and axially substituted boron atom are a class of compounds with interesting optical and redox properties. Here we present our efforts towards expanding this class of compounds using various thiophene substrates that were prepared by cyanation or nitration of 3,4-dibromothiophene. Moreover, we show that one TP derivative forms a 2:1 complex in the solid state with C70.

Heterocyclic-ring condensed benzothiazine compound

The invention provides a novel heterocyclic ring condensed benzothiazine compound which is effective for prevention or remedy of disease, in which histamine, leukotriene and the like participate. The heterocyclic ring condensed benzothiazine compound of the present invention or a pharmacologically acceptable salt thereof is effective for prevention or remedy of disease, in which a chemical mediator, such as histamine, leukotriene and the like, participate, for example, asthma, allergic coryza, atopic dermatitis, hives, hay fever, gastrointestinal allergy, food allergy and the like. Further, the heterocyclic ring condensed benzothiazine compound of the present invention, its pharmacologically acceptable salt or hydrates thereof is represented by the following formula: In the formula, the ring Het represents an unsaturated heterocyclic ring; R1and R2are the same as or different from each other, and each represents halogen atom, a lower alkyl group that may be substituted with a halogen atom, a lower alkoxy group that may be substituted with a halogen atom, a lower alkyl lower alkoxy group, cyano group; D represents a lower alkylene group and the like that may have a substituent; Q represents, for example, the formula —NR20R2(in the formula, R20and R21are the same as or different from each other, and each represents hydrogen atom, a lower alkyl group that may be substituted with a halogen atom, an aryl group that may have a substituent, an arylalkyl group that may have a substituent, a heteroaryl group that may have a substituent or a heteroarylalkyl group that may have a substituent, or R20and R21may form a 3- to 8-membered ring along with the nitrogen atom to which they are bound); and x represents an integer of from 1 to 2.